Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers

Elevated reactive oxygen species (ROS) have been implicated as significant for cancer survival by functioning as oncogene activators and secondary messengers. Hence, the attenuation of ROS-signaling pathways in cancer by antioxidants seems a suitable therapeutic regime for targeting cancers. Low mol...

Full description

Bibliographic Details
Main Authors: Babita Shashni, Yukio Nagasaki
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/2/92
_version_ 1797416532345618432
author Babita Shashni
Yukio Nagasaki
author_facet Babita Shashni
Yukio Nagasaki
author_sort Babita Shashni
collection DOAJ
description Elevated reactive oxygen species (ROS) have been implicated as significant for cancer survival by functioning as oncogene activators and secondary messengers. Hence, the attenuation of ROS-signaling pathways in cancer by antioxidants seems a suitable therapeutic regime for targeting cancers. Low molecular weight (LMW) antioxidants such as 2,2,6,6-tetramethylpyperidine-1-oxyl (TEMPO), although they are catalytically effective in vitro, exerts off-target effects in vivo due to their size, thus, limiting their clinical use. Here, we discuss the superior impacts of our TEMPO radical-conjugated self-assembling antioxidant nanoparticle (RNP) compared to the LMW counterpart in terms of pharmacokinetics, therapeutic effect, and adverse effects in various cancer models.
first_indexed 2024-03-09T06:05:35Z
format Article
id doaj.art-9efa1c5e5acb4a27aa6972a0a486d4dc
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T06:05:35Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-9efa1c5e5acb4a27aa6972a0a486d4dc2023-12-03T12:05:03ZengMDPI AGJournal of Personalized Medicine2075-44262021-02-011129210.3390/jpm11020092Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the CancersBabita Shashni0Yukio Nagasaki1Department of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, Tennoudai 1-1-1, Tsukuba, Ibaraki 305-8573, JapanDepartment of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, Tennoudai 1-1-1, Tsukuba, Ibaraki 305-8573, JapanElevated reactive oxygen species (ROS) have been implicated as significant for cancer survival by functioning as oncogene activators and secondary messengers. Hence, the attenuation of ROS-signaling pathways in cancer by antioxidants seems a suitable therapeutic regime for targeting cancers. Low molecular weight (LMW) antioxidants such as 2,2,6,6-tetramethylpyperidine-1-oxyl (TEMPO), although they are catalytically effective in vitro, exerts off-target effects in vivo due to their size, thus, limiting their clinical use. Here, we discuss the superior impacts of our TEMPO radical-conjugated self-assembling antioxidant nanoparticle (RNP) compared to the LMW counterpart in terms of pharmacokinetics, therapeutic effect, and adverse effects in various cancer models.https://www.mdpi.com/2075-4426/11/2/92cancerreactive oxygen speciesantioxidantself-assembling drug
spellingShingle Babita Shashni
Yukio Nagasaki
Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers
Journal of Personalized Medicine
cancer
reactive oxygen species
antioxidant
self-assembling drug
title Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers
title_full Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers
title_fullStr Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers
title_full_unstemmed Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers
title_short Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers
title_sort newly developed self assembling antioxidants as potential therapeutics for the cancers
topic cancer
reactive oxygen species
antioxidant
self-assembling drug
url https://www.mdpi.com/2075-4426/11/2/92
work_keys_str_mv AT babitashashni newlydevelopedselfassemblingantioxidantsaspotentialtherapeuticsforthecancers
AT yukionagasaki newlydevelopedselfassemblingantioxidantsaspotentialtherapeuticsforthecancers